当前位置:首页 - 行情中心 - 第一医药(600833) - 财务分析 - 现金流量表

第一医药

(600833)

  

流通市值:25.81亿  总市值:25.81亿
流通股本:2.23亿   总股本:2.23亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金515,989,005.692,318,053,301.691,652,800,908.611,105,853,639.48
  收到的税费返还-9,288,614.099,023,181.955,767,087.55
  收到其他与经营活动有关的现金8,015,613.2441,985,335.3627,038,213.2517,174,274.52
  经营活动现金流入小计524,004,618.932,369,327,251.141,688,862,303.811,128,795,001.55
  购买商品、接受劳务支付的现金423,779,496.451,888,641,702.011,327,757,284.68847,728,800.66
  支付给职工以及为职工支付的现金41,546,235.14194,697,548.9995,238,687.0181,494,456.59
  支付的各项税费8,102,672.5960,356,287.734,630,124.0323,890,347.21
  支付其他与经营活动有关的现金42,227,121.67136,751,208.6206,694,586.57120,145,508.01
  经营活动现金流出小计515,655,525.852,280,446,747.31,664,320,682.291,073,259,112.47
  经营活动产生的现金流量净额8,349,093.0888,880,503.8424,541,621.5255,535,889.08
二、投资活动产生的现金流量:
  收回投资收到的现金90,000,000343,700,027.78265,000,000255,000,000
  取得投资收益收到的现金6,864,268.1118,639,088.5615,251,507.6815,132,773.91
  处置固定资产、无形资产和其他长期资产收回的现金净额10,340.0150,835,265.8254,091,026.1189,772.28
  投资活动现金流入小计96,874,608.12413,174,382.16334,342,533.79270,222,546.19
  购建固定资产、无形资产和其他长期资产支付的现金2,564,174.1515,927,763.4112,789,546.097,346,816.86
  投资支付的现金29,000,000433,025,027.78314,700,000299,700,000
  投资活动现金流出小计31,564,174.15448,952,791.19327,489,546.09307,046,816.86
  投资活动产生的现金流量净额65,310,433.97-35,778,409.036,852,987.7-36,824,270.67
三、筹资活动产生的现金流量:
  取得借款收到的现金-99,289,263.8999,289,263.8949,636,541.67
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-99,289,263.8999,289,263.8949,636,541.67
  偿还债务支付的现金49,652,722.22144,283,575.0194,647,033.3494,647,033.34
  分配股利、利润或偿付利息支付的现金347,277.7850,791,648.5551,138,926.331,716,424.99
  支付其他与筹资活动有关的现金12,678,239.4962,389,023.0444,591,269.7230,259,376.31
  筹资活动现金流出小计62,678,239.49257,464,246.6190,377,229.39126,622,834.64
  筹资活动产生的现金流量净额-62,678,239.49-158,174,982.71-91,087,965.5-76,986,292.97
四、汇率变动对现金及现金等价物的影响-93,397.69-1,272,724.99-560,726.39-127,454.08
五、现金及现金等价物净增加额10,887,889.87-106,345,612.89-60,254,082.67-58,402,128.64
  加:期初现金及现金等价物余额322,224,697.48428,870,007.92428,870,007.92428,870,007.92
  期末现金及现金等价物余额333,112,587.35322,524,395.03368,615,925.25370,467,879.28
补充资料:
  净利润-58,536,397.11-14,321,865.08
  资产减值准备-1,648,594.19--
  固定资产和投资性房地产折旧-4,971,920.14-2,505,200.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,971,920.14-2,505,200.94
  无形资产摊销-3,152,727.73-1,543,689.87
  长期待摊费用摊销-7,741,676.44-3,588,850.95
  处置固定资产、无形资产和其他长期资产的损失--50,179,480.75--404,944.23
  固定资产报废损失-340,144.76-100,042.1
  公允价值变动损失-11,419.67--
  财务费用-5,236,916.3-2,309,009.74
  投资损失--11,073,990.93--8,489,595.84
  递延所得税--3,545,115.27--6,235,982.23
  其中:递延所得税资产减少--3,452,923.75--7,801,192.83
    递延所得税负债增加--92,191.52-1,565,210.6
  存货的减少--18,953,456.78--49,747,752.13
  经营性应收项目的减少--27,818,746.79--59,122,085.75
  经营性应付项目的增加-56,592,595.28-128,097,996.78
  现金的期末余额-322,524,395.03-370,467,879.28
  减:现金的期初余额-428,870,007.92-428,870,007.92
  现金及现金等价物的净增加额--106,345,612.89--58,402,128.64
公告日期2026-04-302026-04-092025-10-312025-08-20
审计意见(境内)标准无保留意见
TOP↑